The association between BP and AHA suggests a common autoimmune mechanism, where immune dysregulation may facilitate the production of FVIII inhibitors.[9] Although the exact pathophysiology remains unclear, immune cross-reactivity, epitope spreading, or polyclonal B-cell activation are proposed mechanisms. Here, F8 is linked to autoimmune hemolytic anemia.